Noxopharm Limited
NOXOF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2,320 | $3,009 | $14,011 | $26,796 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $6,085 | $5,213 | $5,799 |
| Inventory | $0 | $0 | $1,146 | $312 |
| Other Curr. Assets | $45 | $66 | $463 | $5,862 |
| Total Curr. Assets | $4,768 | $9,159 | $20,833 | $32,974 |
| Property Plant & Equip (Net) | $6 | $7 | $222 | $484 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2,010 | $962 | $5,539 | $14,395 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2,015 | $969 | $5,760 | $14,880 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,784 | $10,128 | $26,594 | $47,854 |
| Liabilities | – | – | – | – |
| Payables | $649 | $448 | $810 | $959 |
| Short-Term Debt | $0 | $0 | $161 | $232 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $597 | $514 | $1,310 | $5,616 |
| Total Curr. Liab. | $1,246 | $962 | $2,281 | $6,807 |
| LT Debt | $0 | $0 | $0 | $118 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $42 | $93 | $195 | $152 |
| Total NC Liab. | $42 | $93 | $195 | $270 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $161 | $349 |
| Total Liabilities | $1,289 | $1,055 | $2,476 | $7,077 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $74,636 | $74,636 | $74,636 | $72,623 |
| Retained Earnings | -$70,070 | -$72,061 | -$58,803 | -$40,333 |
| AOCI | $930 | $6,498 | $8,285 | $8,487 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $5,495 | $9,073 | $24,118 | $40,776 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6,784 | $10,128 | $26,594 | $47,854 |
| Net Debt | -$2,320 | -$3,009 | -$13,850 | -$26,446 |